Literature DB >> 15206059

Prevalence of antibiotic resistance in anaerobic bacteria: worrisome developments.

David W Hecht1.   

Abstract

Antibiotic-resistant anaerobic bacteria have become increasingly recognized as a confounding factor in the selection of therapeutic agents. The use of potent, broad-spectrum antibiotics as empirical therapy, along with appropriate adjunctive measures, has, in some ways, masked the magnitude of the antibiotic resistance problem that parallels that observed for nonanaerobic pathogens. The use of standardized testing methods that recognize resistance and an understanding of resistance mechanisms have become essential for the treatment of patients and the development of new agents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15206059     DOI: 10.1086/421558

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  37 in total

1.  Comparative Evaluation of the Cytotoxic and Angiogenic Effects of Minocycline and Clindamycin: An In Vitro Study.

Authors:  Nileshkumar Dubey; Jinping Xu; Zhaocheng Zhang; Jacques E Nör; Marco C Bottino
Journal:  J Endod       Date:  2019-05-24       Impact factor: 4.171

2.  In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections.

Authors:  Ellie J C Goldstein; Diane M Citron; Yumi A Warren; Kerin L Tyrrell; C Vreni Merriam; Helen Fernandez
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention.

Authors:  Arturo S Dela Pena; Walter Asperger; Ferdinand Köckerling; Raul Raz; Reinhold Kafka; Brian Warren; Malathi Shivaprakash; France Vrijens; Hilde Giezek; Mark J DiNubile; Christina Y Chan
Journal:  J Gastrointest Surg       Date:  2006-04       Impact factor: 3.452

4.  Prognostic factors and impact of antibiotherapy in 117 cases of anaerobic bacteraemia.

Authors:  R Robert; A Deraignac; G Le Moal; S Ragot; G Grollier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-21       Impact factor: 3.267

Review 5.  Antianaerobic antimicrobials: spectrum and susceptibility testing.

Authors:  Itzhak Brook; Hannah M Wexler; Ellie J C Goldstein
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

6.  Antibiotics in hospital effluents: occurrence, contribution to urban wastewater, removal in a wastewater treatment plant, and environmental risk assessment.

Authors:  Senar Aydin; Mehmet Emin Aydin; Arzu Ulvi; Havva Kilic
Journal:  Environ Sci Pollut Res Int       Date:  2018-11-08       Impact factor: 4.223

Review 7.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

8.  Bacteremia caused by a metronidazole-resistant Prevotella sp. strain.

Authors:  Francine Mory; Jean-Philippe Carlier; Corentine Alauzet; Maxime Thouvenin; Hélène Schuhmacher; Alain Lozniewski
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

9.  Identification of clinically important anaerobic bacteria by an oligonucleotide array.

Authors:  Yu Tzu Lin; Mario Vaneechoutte; Ay Huey Huang; Lee Jene Teng; Hung-Mo Chen; Shu-Li Su; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2010-02-03       Impact factor: 5.948

10.  Ceftaroline plus avibactam demonstrates bactericidal activity against pathogenic anaerobic bacteria in a one-compartment in vitro pharmacokinetic/pharmacodynamic model.

Authors:  Brian J Werth; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.